A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome
Open Access
- 9 December 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 130 (1), 438-450
- https://doi.org/10.1172/jci130976
Abstract
An excess of fecal bile acids (BAs) is thought to be one of the mechanisms for diarrhea-predominant irritable bowel syndrome (IBS-D). However, the factors causing excessive BA excretion remain incompletely studied. Given the importance of gut microbiota in BA metabolism, we hypothesized that gut dysbiosis might contribute to excessive BA excretion in IBS-D. By performing BA-related metabolic and metagenomic analyses in 290 IBS-D patients and 89 healthy volunteers, we found that 24.5% of IBS-D patients exhibited excessive excretion of total BAs and alteration of BA-transforming bacteria in feces. Notably, the increase in Clostridia bacteria (e.g., C. scindens) was positively associated with the levels of fecal BAs and serum 7α-hydroxy-4-cholesten-3-one (C4), but negatively correlated with serum fibroblast growth factor 19 (FGF19) concentration. Furthermore, colonization with Clostridia-rich IBS-D fecal microbiota or C. scindens individually enhanced serum C4 and hepatic conjugated BAs but reduced ileal FGF19 expression in mice. Inhibition of Clostridium species with vancomycin yielded opposite results. Clostridia-derived BAs suppressed the intestinal FGF19 expression in vitro and in vivo. In conclusion, this study demonstrates that the Clostridia-rich microbiota contributes to excessive BA excretion in IBS-D patients, which provides a mechanistic hypothesis with testable clinical implications.Keywords
Funding Information
- the Innovation and Technology Fund, HKSAR (ITS-148-14FP)
- Guangdong-Hong Kong Technology Cooperation Funding Scheme (2016A050503039)
- Guangzhou Science and Technology Program key projects (201604020005)
- Shenzhen Science and Technology Innovation Committee Grant (JCYJ20160331190123578)
- Shenzhen Science and Technology Innovation Committee Grant (JCYJ20170413170320959)
This publication has 74 references indexed in Scilit:
- Methods for Diagnosis of Bile Acid Malabsorption in Clinical PracticeClinical Gastroenterology and Hepatology, 2013
- Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated methodJournal of Lipid Research, 2012
- A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With DiarrheaGastroenterology, 2011
- Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel FunctionClinical Gastroenterology and Hepatology, 2010
- Chronic Diarrhea Due to Excessive Bile Acid Synthesis and Not Defective Ileal Transport: A New Syndrome of Defective Fibroblast Growth Factor 19 ReleaseClinical Gastroenterology and Hepatology, 2009
- Measurement of serum 7α‐hydroxy‐4‐cholesten‐3‐one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography‐tandem mass spectrometryNeurogastroenterology & Motility, 2009
- Review: The treatment of irritable bowel syndromeTherapeutic Advances in Gastroenterology, 2009
- A Rat Model of Chronic Postinflammatory Visceral Pain Induced by Deoxycholic AcidGastroenterology, 2008
- Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorptionEuropean Journal of Gastroenterology & Hepatology, 2006
- Primary bile acid diarrhoea without an ileal carrier defect: quantification of active bile acid transport across the ileal brush border membrane.Gut, 1991